Diagnosis and the debatable issues of the treatment of heart failure with preserved ejection fraction
Heart failure with preserved fraction (HFpEF) amount for a half of the general heart failure and increasing progressively. In this review we discuss the issues of pathogenesis of HFpEF, illuminated in the recent literature in the last years. Considering the heterogeneity of the pathophysiology of th...
Main Authors: | Z. M Akhilgova, M. V Kurkina, Z. R Dzhioeva, A. A Puhaeva, A. G Avtandilov |
---|---|
Format: | Article |
Language: | English |
Published: |
Concilium Medicum
2018-12-01
|
Series: | КардиоСоматика |
Subjects: | |
Online Access: | https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45972/pdf |
Similar Items
-
Dynamics of Vascular Stiffness and Endothelial Function in Combination Therapy of Heart Failure with Preserved Ejection Fraction
by: Z. M. Akhilgova, et al.
Published: (2020-07-01) -
Effect of combination antihypertensive therapy, including renin-angiotensin-aldosterone system inhibitors, on oxidative stress and arterial remodeling in hypertensive patients with heart failure with preserved ejection fraction
by: Z. M. Akhilgova, et al.
Published: (2021-06-01) -
Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis
by: Chao Ma, et al. -
Heart failure with preserved ejection fraction – onset
by: Branimir Kanazirev
Published: (2021-07-01) -
Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations
by: Dzhioeva O, et al.
Published: (2020-08-01)